Ever read two kratom headlines and wondered how they could be talking about the same plant? You’re not alone. Before deciding what a headline means, it helps to ask what was actually studied—and what the study can tell us.
Start with the original source
KratomAnswers.org brings together research and policy references. We use it as a starting point, then read the linked work. A helpful summary still needs checking: when was it written, which product was studied, and does its wording match the findings?
A survey, a lab study, and a clinical trial answer different questions
A survey can describe what participants say they experienced. It cannot, by itself, establish that a product caused a benefit or is safer than another treatment. Laboratory and animal studies can explore mechanisms and guide further work; their findings do not automatically apply to people using retail products. Controlled human studies can address different questions, but their size, duration, comparison groups, and product details still matter.
A policy decision is not a medical approval
WHO’s May 2023 surveillance document records the committee’s 2021 conclusion that there was insufficient evidence to recommend a critical review of kratom and its two named alkaloids, and that they should remain under surveillance. That is a drug-control assessment, not an approval of kratom as a treatment or a declaration that all products are safe. Read WHO’s document.
What FDA says—and what remains unknown
FDA says there are no FDA-approved kratom drug products and that kratom cannot lawfully be marketed as a dietary supplement or added to conventional foods. It warns about adverse events including liver toxicity, seizures, and substance use disorder. The agency also notes that deaths associated with kratom usually involved other drugs, making kratom’s contribution unclear. Its page identifies important research gaps. These points deserve accurate reporting together. Read FDA’s explanation.
Check the product, not just the word “kratom”
FDA distinguishes botanical kratom from products with concentrated 7-hydroxymitragynine, or 7-OH. Evidence about one preparation should not be stretched to cover every powder, extract, or tablet. Look for the actual composition, amount, and testing details in the source.
Our promise to readers
We’ll link the evidence, explain the limitations, and tell you when an answer is still unsettled. No miracle claims, no dramatic shortcuts—just information you can check. Reviewed October 6, 2026.
Owner / sponsor: Colorado Kratom is funded by Laughing Lion Herbs. Find our Colorado Springs store.